Sientra files for Chapter 11 bankruptcy, operations will continue

Breast implant manufacturer Sientra announced on Feb. 13, 2024, that it filed for Chapter 11 bankruptcy as it pursues a sale of the company.

In a letter to customers, Sientra President and CEO Ron Menezes said the company will continue operations and provide continuous access to its products and services.

"Please be assured that we expect to continue operations while this process is ongoing," wrote Mr. Menezes. "Sientra will utilize existing cash reserves and $22.5 million in new money debtor-in-possession financing from our existing lenders to continue company operations while the strategic sale is ongoing."

Multiple parties have reportedly expressed interest in acquiring Sientra, and additional updates will be available on the Sientra website and via subsequent emails.

"Our goal is to emerge from this process with increased financial stability and positioned for long-term success under new ownership," said Mr. Menezes. "In the interim, we remain focused on providing our customers with quality service, continuous manufacturing and access to our products."

Sientra invites ASPS members to contact their sales representatives or email about@sientra.com with any questions or concerns.

Court filings and additional information can be found at https://dm.epiq11.com/Sientra.